The use of Thiocetam in the complex therapy of combat-related brain contusion

Each patient presents a unique set of characteristics and challenges when it comes to acute cerebral ischemia resulting from craniocerebral injury. The aim this study is investigate the utilization Thiocetam as part comprehensive treatment approach for combat-related contusion assess therapeutic effects in patients with mild moderate closed combat trauma comparison standard basic therapy. Materials methods. 79 were examined. Among them, 76 experienced due an explosive blast injury, which included conditions such brain concussion, contusion, cranial vault fractures. All admitted department during period their injuries. During study, various clinical functional methods employed condition central nervous system. These used evaluate complex administered patients. Results. administration did not result increase excitability, nervousness, or sleep disturbances. Furthermore, examination autonomic reactivity following revealed that indicator normal increased 60 % treated group, whereas only 42 control group. Additionally, initially heightened vegetative reactions decrease 42.8 17.9 while group saw 38.5 23.1 %. In terms outcomes, positive effect was observed 94 Thiocetam-treated within first 5 days. comparison, showed cases. This improvement evident both field based on indicators EEG data, well cognitive function assessed by MMSE test scale. Conclusions. phase enhances neuroprotective combined drug Thiocetam, possesses nootropic effects, offers advantage reducing even avoiding side commonly associated traditional racetam nootropics.